» Articles » PMID: 32870574

Composition of Hemidesmosomes in Basal Keratinocytes of Normal Buccal Mucosa and Oral Lichen Planus

Overview
Journal Eur J Oral Sci
Specialty Dentistry
Date 2020 Sep 2
PMID 32870574
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Oral lichen planus (OLP) is a chronic inflammatory disease displaying ultrastructural disturbances in epithelial hemidesmosomes. The expression of several key hemidesmosomal components in OLP as well as in normal buccal mucosa is, however, unknown. The aim of the study was therefore to examine intracellular and extracellular components involved in hemidesmosomal attachment, in OLP (n = 20) and in normal buccal mucosa (n = 10), by immunofluorescence. In normal buccal mucosa, laminin-α3γ2, integrin-α6β4, CD151, collagen α-1(XVII) chain, and dystonin showed linear expression along the basal membrane, indicating the presence of type I hemidesmosomes. Plectin stained most epithelial cell membranes and remained unphosphorylated at S4642. In OLP, most hemidesmosomal molecules examined showed disturbed expression consisting of discontinuous increases, apicolateral location, and/or intracellular accumulation. Plectin showed S4642-phosphorylation at the basement membrane, and deposits of laminin-α3 and laminin-γ2 were found within the connective tissue. The disturbed expression of hemidesmosomal proteins in OLP indicates deficient attachment of the basal cell layer, which can contribute to detachment and cell death of basal keratinocytes seen in the disease.

Citing Articles

Plectin: Dual Participation in Tumor Progression.

Wang Z, Wang W, Luo Q, Song G Biomolecules. 2024; 14(9).

PMID: 39334817 PMC: 11430127. DOI: 10.3390/biom14091050.


Role of Hemidesmosomes in Oral Carcinogenesis: A Systematic Review.

Nguyen J, Chong T, Elmi H, Ma J, Madi J, Mamgain A Cancers (Basel). 2023; 15(9).

PMID: 37173998 PMC: 10177336. DOI: 10.3390/cancers15092533.


The extracellular matrix alteration, implication in modulation of drug resistance mechanism: friends or foes?.

Jurj A, Ionescu C, Berindan-Neagoe I, Braicu C J Exp Clin Cancer Res. 2022; 41(1):276.

PMID: 36114508 PMC: 9479349. DOI: 10.1186/s13046-022-02484-1.